MedPath

An experimental study to evaluate the effectiveness of Multi-component Intervention (MCI) on Radiotherapy Induced Fatigue and its correlates among breast cancer patients.

Not Applicable
Conditions
Health Condition 1: D249- Benign neoplasm of unspecified breast
Registration Number
CTRI/2022/03/041283
Lead Sponsor
Blessy Mohandass
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Female Breast cancer patients who are:

above the age of 18 years

willing to participate

prescribed radiation therapy for at least 6 weeks

having smartphone

able to read and understand Hindi or English

Exclusion Criteria

Females Breast cancer patients

diagnosed with comorbidities like severe depression, cardiovascular diseases, endocrine diseases, and sleep disorders

unable to follow instructions owing to compromised physical and mental health

enrolled in another study that involves a similar intervention

having compliance less than 75% for MCI

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean Fatigue Scores <br/ ><br>Mean Anxiety Scores <br/ ><br>Mean Depression Score <br/ ><br>Mean Sleep Quality Index <br/ ><br>Mean nutritional status scoreTimepoint: Four weeks and Six Weeks
Secondary Outcome Measures
NameTimeMethod
ser Satisfaction for MCITimepoint: Six Weeks
© Copyright 2025. All Rights Reserved by MedPath